| 2024/09/27 08:27:49 | |
|---|---|
| Price | |
| 74.00 EUR | |
| Difference | -0.67% (-0.50) |
General attributes
| ISIN | US1011371077 |
| Symbol | BSX |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 109,472 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 74.00 EUR (122) |
| Ask (Ask size) | 75.00 EUR (120) |
| Open | 75.00 EUR |
| High | 75.00 EUR |
| Low | 74.00 EUR |
| Close (prev. day) | 74.50 EUR |
| VWAP | 74.25 EUR |
| Volume (pcs) | 40 |
| Trading volume | 2,970.00 |
| Number of trades | 2 |
| Last size | 30 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: BOSTON SCIENTIFIC CORP |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/09/11 |
|
Global Equity Ratings |
|
| 2024/09/05 |
|
Global Equity Ratings |
|
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/09/27 08:27:49 | |
|---|---|
| Price | |
| 74.00 EUR | |
| Difference | -0.67% (-0.50) |
General attributes
| ISIN | US1011371077 |
| Symbol | BSX |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 109,472 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 74.00 EUR (122) |
| Ask (Ask size) | 75.00 EUR (120) |
| Open | 75.00 EUR |
| High | 75.00 EUR |
| Low | 74.00 EUR |
| Close (prev. day) | 74.50 EUR |
| VWAP | 74.25 EUR |
| Volume (pcs) | 40 |
| Trading volume | 2,970.00 |
| Number of trades | 2 |
| Last size | 30 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +18.90% | +49.03% | +95.23% |
| Perf (abs.) | +11.84 | +24.51 | +36.34 |
| Beta | 0.52 | 0.53 | 0.71 |
| Volatility | 19.06 | 19.76 | 22.00 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 75.30 EUR (1,117) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 73.70 EUR (1,060) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 71.38 EUR (1,050) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 62.45 EUR (818) |
| YTD High | date | 76.50 EUR (2024/09/10) |
| YTD Low | date | 52.14 EUR (2024/01/02) |
| 52 Weeks High | date | 76.50 EUR (2024/09/10) |
| 52 Weeks Low | date | 45.99 EUR (2023/10/13) |
All listings for BOSTON SCIENTIFIC CORP
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/09/27 | 09:04 | 75.00 EUR | 0.00 | 1 |
| Vienna Stock Exchange | 2024/09/27 | 09:05 | 74.50 EUR | 0.00 | 1 |
| Tradegate | 2024/09/27 | 08:27 | 74.00 EUR | 0.00 | 2 |
| Stuttgart | 2024/09/27 | 08:03 | 74.00 EUR | 0.00 | 1 |
| NYSE | 2024/09/26 | 22:00 | 83.08 USD | 337.50 | 46,164 |
| Munich | 2024/09/27 | 08:01 | 74.00 EUR | 0.00 | 1 |
| London Stock Exchange | 2024/09/25 | 15:30 | 83.96 USD | 0.00 | 2 |
| Frankfurt | 2024/09/27 | 08:49 | 74.00 EUR | 0.00 | 1 |
| Euronext Milan MTF Trading After Hours | 2024/09/06 | 18:03 | 74.00 EUR | 0.00 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/09/26 | 17:44 | 74.50 EUR | 0.00 | 1 |
| Duesseldorf | 2024/09/27 | 08:10 | 73.50 EUR | 0.00 | 1 |
| Berlin | 2024/09/27 | 08:08 | 74.00 EUR | 0.00 | 1 |
Company Logo
Contact Details
| BOSTON SCIENTIFIC CORP. |
| - - |
| 300 Boston Scientific Way - 01752-1234 Marlborough |
| Telefon: +1-508-683-4000 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: BOSTON SCIENTIFIC CORP | |
Company Profile
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA. |
Members of Management Board
| Cheryl Pegus | Member of Board of Directors |
| Ellen Zane | Member of Board of Directors |
| Jessica Mega | Member of Board of Directors |
| Charles Dockendorff | Member of Board of Directors |
| David Habiger | Member of Board of Directors |
| David Wichmann | Member of Board of Directors |
| Edward Ludwig | Member of Board of Directors |
| John Sununu | Member of Board of Directors |
| Susan Morano | Member of Board of Directors |
| Yoshiaki Fujimori | Member of Board of Directors |
| Michael F. Mahoney | Chairman of Managing Board |
| Arthur Butcher | Member of Executive Committee |
| Daniel J. Brennan | Member of Executive Committee |
| Eric Thépaut | Member of Executive Committee |
| Jeff Mirviss | Member of Executive Committee |
| Jodi Eddy | Member of Executive Committee |
| Joseph M. Fritzgerald | Member of Executive Committee |
| Kenneth Stein | Member of Executive Committee |
| Mary Beth Moynihan | Member of Executive Committee |